WebJan 27, 2015 · Lund, Sweden, 2015-01-27 08:23 CET (GLOBE NEWSWIRE) -- Two clinical studies on EXINI’s imaging biomarker BSI (Bone Scan Index) have been approved for the 2015 American Society of Clinical ...
Breakthrough for EXINI, FDA approval for EXINI bone™.
WebMay 26, 2024 · Bone scintigraphy is one of the first-line imaging modalities for the screening and follow up of bone metastasis in patients with prostate cancer. The amount (%) of bone metastasis can be calculated using a … WebMay 4, 2024 · Lantheus Holdings subsidiary EXINI Diagnostics has secured CE mark approval for its artificial intelligence (AI) based and deep learning-enabled medical device software called aPROMISE. The software helps healthcare professionals and researchers conduct quantitative assessment of prostate-specific membrane antigen (PSMA) PET/CT … das buch puhdys text
EXINI´s imaging biomarker BSI to be presented at important
WebDec 14, 2024 · Tests and procedures used to diagnose breast cancer include: Breast exam. Your doctor will check both of your breasts and lymph nodes in your armpit, feeling for any lumps or other abnormalities. … WebEXINI: New BSI-results to be presented at cancer conference New BSI-data have been generated using the software package, EXINI bone BSI , for a prostate cancer project. WebApr 10, 2024 · Breast cancer and prostate cancer are sex hormone-dependent cancers, and estrogen or androgen suppression therapy is the standard treatment. Cancer treatment-induced bone loss (CTIBL): bone loss and osteoporosis have become important side effects of these therapies. To summarize the current evidence … das buch mose